Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens.

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. Abstract Text:

Qingyu Zhou,Ping Guo,Xiaomin Wang,Silpa Nuthalapati,James M Gallo,

Metronomic dosed (MD) chemotherapy as opposed to conventional dosed (CD) chemotherapy is considered an alternate strategy to target angiogenesis and limit host toxicity. Although this approach is promising, there has not been any attempt to define optimal metronomic dosing regimens by integrating pharmacokinetic (PK) with pharmacodynamic (PD) measurements. The aim of this study was to compare the pharmacokinetics and pharmacodynamics of temozolomide [TMZ, 8-carbamoyl-3-methylidazo(5,1-d)-1,2,3,5-terrazin-4(3H)-one] after MD and CD regimens. In vivo studies were carried out in xenografted athymic rats treated with either 18 mg/kg/day TMZ for 5 days or 3.23 mg/kg/day TMZ for 28 days. PK studies were performed on the first and last days of dosing. PD measurements consisted of gene and protein expression of various angiogenic markers, tumor size, tumor pH, and interstitial fluid pressure (IFP). The results demonstrated that the PK parameters (total clearance, volume of distribution, and tumor/plasma accumulation) were quite similar for MD and CD groups, consistent with the linear PK properties of TMZ. Both TMZ treatment schedules caused a significant decrease in IFP and tumor size compared with vehicle control treatment, demonstrating comparable effectiveness of MD and CD regimens. Using real-time polymerase chain reaction and Western blot analyses, some differences were noted in expression levels of vascular endothelial growth factor and hypoxia inducible factor-1alpha, suggesting that the MD regimen may be superior to the CD regimen by preventing tumors from progressing to a proangiogenic state. In conclusion, several PK/PD factors contributing to the antitumor activity of the MD TMZ therapy have been identified and form a foundation for further investigations of low-dose TMZ regimens.

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. Publishing Authors By Initials

Q Zhou,P Guo,X Wang,S Nuthalapati,JM Gallo,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: The Journal of pharmacology and experimental thera

VOLUME: 321

Page Numbers: 265-75

Journal Abbreviation: J. Pharmacol. Exp. Ther.

ISSN: 0022-3565

DAY: 26

MONTH: 01

YEAR: 2007

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376362

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. Keywords Mesh Terms:

KEYWORDS: Reverse Transcriptase Polymerase Chain R

MESH TERMS: genetics

Chemical & Substance for Abstract: Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. Information

Substance Name: temozolomide

Registry Number: 85622-93-1

Grant and Affiliation Information for Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens.

AFFILIATION: Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, 3307 N. Broad St., Philadelphia, PA 19140, USA.

Country: United States

AGENCY: United States NCI

GRANT: CA85577

ACRONYM: CA

MEDLINETA: J Pharmacol Exp Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens Related Publications

• A field study on fertility and purity of sex-sorted cattle sperm.
• A functional role for EGFR signaling in myelination and remyelination.
• Advances in corneal stem-cell transplantation in rabbits with severe ocular alkali burns.
• Association between threatened pre-term labour and periodontal disease: does a relationship exist? A matched case-control study.
• Axon extension in the fast and slow lanes: substratum-dependent engagement of myosin II functions.
• Bisphenol-A alters gene expression and functional parameters in molluscan hepatopancreas.
• Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization.
• Cerebral cholesterol granuloma: case report.
• Chronic medical conditions and wishes to die among older primary care patients.
• Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
• Determination of methotrexate and its major metabolite 7-hydroxymethotrexate in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry.
• Development of an auxiliary system for the execution of vascular catheter interventions with a reduced radiological risk; system description and first experimental results.
• Developmental regulation of sensory axon regeneration in the absence of growth cones.
• Differential synaptic integration of interneurons in the outer and inner molecular layers of the developing dentate gyrus.
• Dilation of intercellular spaces is associated with laryngo-pharyngeal reflux: an ultrastructural morphometric analysis of laryngeal epithelium.
• Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis.
• Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4.
• Hippocampus, temporal context and taste memories.
• Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.
• Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism.
• Maffucci's syndrome complicated by intracranial chondrosarcoma: two new illustrative cases.
• Nonfunctional tooth contact in healthy controls and patients with myogenous facial pain.
• Parapharyngeal high-grade malignant schwannoma with extension to infratemporal and pterygopalatine fossa.
• Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens.
• Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain disposition.
• Pyogranulomatous panniculitis caused by Mycobacterium alvei in a cat.
• Regulation of actomyosin contractility by PI3K in sensory axons.
• Regulation of axon guidance and extension by three-dimensional constraints.
• The role of patient personality in the identification of depression in older primary care patients.
• Use of preventive care by the working poor in the United States.